Cargando…

Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial

INTRODUCTION: Considering the proven therapeutic effect of botulinum toxin and the pathophysiology of seborrheic dermatitis, conflicting hypotheses have been put forward regarding the effect of injection of this toxin on the improvement or exacerbation of seborrheic dermatitis. Because of the lack o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazargan, Afsaneh Sadeghzadeh, Tabavar, Anahita, Roohaninasab, Masoumeh, Ali, Zahra Naeimaei, Tavana, Zeynab, Montazeri, Seyede Saba Mostafavi, Jafarzadeh, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517391/
https://www.ncbi.nlm.nih.gov/pubmed/37881062
http://dx.doi.org/10.1111/srt.13478
_version_ 1785109310142939136
author Bazargan, Afsaneh Sadeghzadeh
Tabavar, Anahita
Roohaninasab, Masoumeh
Ali, Zahra Naeimaei
Tavana, Zeynab
Montazeri, Seyede Saba Mostafavi
Jafarzadeh, Alireza
author_facet Bazargan, Afsaneh Sadeghzadeh
Tabavar, Anahita
Roohaninasab, Masoumeh
Ali, Zahra Naeimaei
Tavana, Zeynab
Montazeri, Seyede Saba Mostafavi
Jafarzadeh, Alireza
author_sort Bazargan, Afsaneh Sadeghzadeh
collection PubMed
description INTRODUCTION: Considering the proven therapeutic effect of botulinum toxin and the pathophysiology of seborrheic dermatitis, conflicting hypotheses have been put forward regarding the effect of injection of this toxin on the improvement or exacerbation of seborrheic dermatitis. Because of the lack of consistent studies investigating this relationship, we decided to conduct this study to investigate the effect of local botulinum toxin injection on sebum production and improvement or worsening of seborrheic dermatitis lesions. METHOD: This study was a prospective, single‐arm clinical trial that involved the injection of botulinum toxin into 20 patients with complaints of skin wrinkles and simultaneous symptoms of seborrheic dermatitis. The trial was conducted at a dermatology clinic between March 2019 and March 2021. Two important characteristics of these patients were seborrheic dermatitis on the face or scalp and a referral for botulinum toxin injection to remove facial wrinkles. The Seborrheic Dermatitis Area and Severity Index (SDASI) was used to determine the severity of symptoms. RESULTS: In study of 20 patients with an average age of 40 years, despite the decrease in the average scores of all examined criteria of seborrheic dermatitis symptoms in study, 1 month after botulinum toxin injection, no significant effect of using this toxin was seen on the improvement of patients’ symptoms (p value >0.05). CONCLUSION: Despite the emphasis of many studies on the effectiveness of botulinum toxin in reducing the activity of sebaceous glands, the use of botulinum toxin as a therapeutic modality for control the symptoms of seborrheic dermatitis is not suggested by this study. Conducting studies in which the location and technique of injection and the follow‐up intervals of patients in them are based on the standard of other studies, are the suggestions made by comparing the results and method of the current study with other studies.
format Online
Article
Text
id pubmed-10517391
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105173912023-09-24 Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial Bazargan, Afsaneh Sadeghzadeh Tabavar, Anahita Roohaninasab, Masoumeh Ali, Zahra Naeimaei Tavana, Zeynab Montazeri, Seyede Saba Mostafavi Jafarzadeh, Alireza Skin Res Technol Original Articles INTRODUCTION: Considering the proven therapeutic effect of botulinum toxin and the pathophysiology of seborrheic dermatitis, conflicting hypotheses have been put forward regarding the effect of injection of this toxin on the improvement or exacerbation of seborrheic dermatitis. Because of the lack of consistent studies investigating this relationship, we decided to conduct this study to investigate the effect of local botulinum toxin injection on sebum production and improvement or worsening of seborrheic dermatitis lesions. METHOD: This study was a prospective, single‐arm clinical trial that involved the injection of botulinum toxin into 20 patients with complaints of skin wrinkles and simultaneous symptoms of seborrheic dermatitis. The trial was conducted at a dermatology clinic between March 2019 and March 2021. Two important characteristics of these patients were seborrheic dermatitis on the face or scalp and a referral for botulinum toxin injection to remove facial wrinkles. The Seborrheic Dermatitis Area and Severity Index (SDASI) was used to determine the severity of symptoms. RESULTS: In study of 20 patients with an average age of 40 years, despite the decrease in the average scores of all examined criteria of seborrheic dermatitis symptoms in study, 1 month after botulinum toxin injection, no significant effect of using this toxin was seen on the improvement of patients’ symptoms (p value >0.05). CONCLUSION: Despite the emphasis of many studies on the effectiveness of botulinum toxin in reducing the activity of sebaceous glands, the use of botulinum toxin as a therapeutic modality for control the symptoms of seborrheic dermatitis is not suggested by this study. Conducting studies in which the location and technique of injection and the follow‐up intervals of patients in them are based on the standard of other studies, are the suggestions made by comparing the results and method of the current study with other studies. John Wiley and Sons Inc. 2023-09-23 /pmc/articles/PMC10517391/ /pubmed/37881062 http://dx.doi.org/10.1111/srt.13478 Text en © 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Bazargan, Afsaneh Sadeghzadeh
Tabavar, Anahita
Roohaninasab, Masoumeh
Ali, Zahra Naeimaei
Tavana, Zeynab
Montazeri, Seyede Saba Mostafavi
Jafarzadeh, Alireza
Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial
title Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial
title_full Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial
title_fullStr Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial
title_full_unstemmed Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial
title_short Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: A prospective, single‐arm clinical trial
title_sort evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: a prospective, single‐arm clinical trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517391/
https://www.ncbi.nlm.nih.gov/pubmed/37881062
http://dx.doi.org/10.1111/srt.13478
work_keys_str_mv AT bazarganafsanehsadeghzadeh evaluationoftheeffectofbotulinumtoxininjectioninaggravatingorimprovingseborrheicdermatitissymptomsaprospectivesinglearmclinicaltrial
AT tabavaranahita evaluationoftheeffectofbotulinumtoxininjectioninaggravatingorimprovingseborrheicdermatitissymptomsaprospectivesinglearmclinicaltrial
AT roohaninasabmasoumeh evaluationoftheeffectofbotulinumtoxininjectioninaggravatingorimprovingseborrheicdermatitissymptomsaprospectivesinglearmclinicaltrial
AT alizahranaeimaei evaluationoftheeffectofbotulinumtoxininjectioninaggravatingorimprovingseborrheicdermatitissymptomsaprospectivesinglearmclinicaltrial
AT tavanazeynab evaluationoftheeffectofbotulinumtoxininjectioninaggravatingorimprovingseborrheicdermatitissymptomsaprospectivesinglearmclinicaltrial
AT montazeriseyedesabamostafavi evaluationoftheeffectofbotulinumtoxininjectioninaggravatingorimprovingseborrheicdermatitissymptomsaprospectivesinglearmclinicaltrial
AT jafarzadehalireza evaluationoftheeffectofbotulinumtoxininjectioninaggravatingorimprovingseborrheicdermatitissymptomsaprospectivesinglearmclinicaltrial